BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12442394)

  • 1. [Detection of hepatitis B core antigen and antibody].
    Chayama K
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):253-7. PubMed ID: 12442394
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of hepatitis B core antibody (including IgM and IgA class antibodies)].
    Tsuge M; Chayama K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():129-33. PubMed ID: 15453301
    [No Abstract]   [Full Text] [Related]  

  • 3. [IgM and IgA antibodies to hepatitis B core antigen].
    Suga M
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):258-64. PubMed ID: 12442395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Viral marker related to antigen and antibody of hepatitis B virus].
    Arase Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():439-42. PubMed ID: 20942098
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic tests: Serological markers of hepatitis B virus].
    Daikoku M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():404-7. PubMed ID: 16111286
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical view of acute hepatitis B].
    Tanaka N; Arakawa Y; Moriyama M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():242-7. PubMed ID: 15453323
    [No Abstract]   [Full Text] [Related]  

  • 7. Surveillance and treatment protocols to detect and treat hepatitis B virus reactivation in hepatitis B surface antigen-negative/antibody to hepatitis B core antigen-positive patients receiving chemotherapy for onco-hematologic malignancies.
    Marignani M; Marzano A
    J Clin Oncol; 2011 Mar; 29(8):e210; author reply e211. PubMed ID: 21220585
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of HBV-DNA in chronic hepatitis patients without any viral markers and its correlation with anti-HBc titer].
    Torii N; Hasegawa K; Yamauchi K; Hayashi N
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):565-8. PubMed ID: 12442445
    [No Abstract]   [Full Text] [Related]  

  • 9. A multiple centre clinical study of third-generation enzyme immunoassays for hepatitis B surface antigen and hepatitis B core IgM class antibody.
    Jakob R
    Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):259-66. PubMed ID: 8318575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a double-antigen sandwich ELISA for effective detection of human hepatitis B core antibody.
    Deng LJ; Xu Y; Huang J
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):515-26. PubMed ID: 18242704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence.
    Núñez M
    Hepatology; 2010 Mar; 51(3):1087-8. PubMed ID: 19960553
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic HBsAg-negative liver disease. Presence of the markers of hepatitis B virus (HBV) infection and their possible meaning].
    Diodati G; Pontisso P; Pornaro E; Stenico D; Bonetti P; Realdi G; Ruol A
    Ann Ital Med Int; 1987; 2(3):195-200. PubMed ID: 3275282
    [No Abstract]   [Full Text] [Related]  

  • 13. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
    Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
    Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HBe antigen and HBe antibody].
    Arase Y; Kumada H
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):247-52. PubMed ID: 12442393
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-HB-core antibodies as a surrogate marker in blood donors].
    Blejer JL; Saguier MC; Salamone HJ
    Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
    [No Abstract]   [Full Text] [Related]  

  • 17. [The prevalence of hepatitis C antibodies among volunteer blood donors with elevated blood transaminase and antibodies to the B virus core antigen].
    Gavilán Carrasco JC; González Santos P; Rosario Díaz E
    Rev Clin Esp; 1996 May; 196(5):277-80. PubMed ID: 8768025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IgM anti-HBc in the differential diagnosis of co- and HDV superinfection].
    Fedorchenko SV; Vozianova SV
    Ter Arkh; 1991; 63(11):55-8. PubMed ID: 1810065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B virus markers in the internist's practice].
    Ivashkin VT; Khazanov AI; Ivlev AS; Vasil'eva AP; Rumiantsev ON; Krivoruchko VA; Lytsar' BN; Izgorodin AS
    Klin Med (Mosk); 1991 Sep; 69(9):51-4. PubMed ID: 1803151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.